Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Caribou Biosciences (CRBU) has disclosed Non-cash Items for 3 consecutive years, with $1.9 million as the latest value for Q2 2022.

  • On a quarterly basis, Non-cash Items fell 63.44% to $1.9 million in Q2 2022 year-over-year; TTM through Jun 2022 was $1.9 million, a 63.44% decrease, with the full-year FY2021 number at $50.1 million, up 622.83% from a year prior.
  • Non-cash Items was $1.9 million for Q2 2022 at Caribou Biosciences, up from $1.6 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $50.1 million in Q4 2021 to a low of $1.6 million in Q1 2022.
  • A 3-year average of $11.4 million and a median of $5.2 million in 2021 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: surged 622.83% in 2021, then plummeted 83.26% in 2022.
  • Caribou Biosciences' Non-cash Items stood at $6.9 million in 2020, then soared by 622.83% to $50.1 million in 2021, then plummeted by 96.19% to $1.9 million in 2022.
  • Per Business Quant, the three most recent readings for CRBU's Non-cash Items are $1.9 million (Q2 2022), $1.6 million (Q1 2022), and $50.1 million (Q4 2021).